Effect of Low Dose Antioxidant Vitamin and Trace Element Supplementation on the Urinary Concentrations of Thromboxane and Prostacyclin Metabolites

Journal of the American College of Nutrition

Volumn 26, Issue 5, 2007, Pages 405-411

  Arnaud, Josiane ^a,b,c   Bost, Muriel ^a,d   Vitoux, Dominique ^a,e   Hercberg, Serge ^a,f   Roussel, Anne Marie ^a,c   Chappuis, Philippe ^a,g   Faure, Henri ^b   Labarère, José ^b   Galan, Pilar ^f   Bordet, Jean Claude ^d  

^a SFERETE Société Francophone d'Etudes et de Recherche sur les Eléments Toxiques et Essentiels   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIV GRENOBLE ALPES   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f Cnam Paris 13 CRNH d'lle de France SMBH ^*  (France)

^g HÔPITAL LARIBOISIÈRE   (France)

Author keywords

Antioxidant; Prostaglandins; Thromboxane; Trace elements; Vitamins

Indexed keywords

11 OXOTHROMBOXANE B2; 2,3 DINOR 6 OXOPROSTAGLANDIN F1 ALPHA; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; PROSTACYCLIN; SELENIUM; THROMBOXANE; TRACE ELEMENT; VITAMIN; ZINC;

ADULT; ARTICLE; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LOW DRUG DOSE; MALE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; URINARY EXCRETION; URINE LEVEL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ZINC BLOOD LEVEL;

EID: 34848892140     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2007.10719629     Document Type: Article

References (41)

1. Bonney RC: Cardiovascular disease: overview of a world pandemic. Eur Clin Lab February: 18-19, 2004.
2. Calzada C, Bruckdorfer KR, Rice-Evans CA: The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 128: 97-105, 1997.
3. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Luedin E: Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidant: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr 57: 787S-797S, 1993.
4. Wolters M, Hermann S, Hahn A: Effects of 6-months multivitamin supplementation on serum concentrations of alpha-tocopherol, beta-carotene, and vitamin C in healthy elderly women. Int J Vitam Nutr Res 74: 161-168, 2004.
5. Wrieden WL, Hannah MK, Bolton-Smith C, Tavendale R, Morrison C, Tunstall-Pedoe H: Plasma vitamin C and food choice in the third Glasgow MONICA population survey. J Epidemiol Community Health 54: 355-360, 2000.
6. Cueto SM, Romney AD, Wang Y, Walsh SW: -carotene attenuates peroxide-induced vasoconstriction in the human placenta. J Soc Gynecol Invest 4: 64-71, 1997.
7. Perona G, Schiavon R, Guidi GC, Veneri D, Minuz P: Selenium dependent glutathion peroxidase: a physiological regulatory system for platelet function. Thromb Haemost 64: 312-318, 1990.
8. Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D: Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism and plasma prostacyclin levels. Am J Clin Nutr 47: 700-706, 1988.
9. Vila L: Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med Res Rev 24: 399-424, 2004.
10. Vitoux D, Chappuis P, Arnaud J, Bost M, Accominotti M, Roussel AM: Sélénium, glutathion peroxydase, peroxydes et fonctions plaquettaires. Ann Biol Clin 54: 181-187, 1996.
11. Smith WL, Marnett LJ, de Witt DL: Prostaglandin and thromboxane biosynthesis. Pharmacol Ther 49: 153-179, 1991.
12. Ricetti MM, Guidi GC, Tecchio C, Bellisola G, Rigo A, Perona G: Effects of sodium selenite on in vitro interactions between platelets and endothelial cells. Int J Clin Lab Res 29: 80-84, 1999.
13. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, Roussel AM, Favier A, Briancon S: The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164: 2335-2342, 2004.
14. Bourgeois CF, Chartois RR, Counstans MF, George PR: Automated determination of vitamin C in foodstuffs and biological tissues. Analusis 9: 519-525, 1989.
15. Arnaud J, Fortis I, Blachier S, Kia D, Favier A: Simultaneous determination of retinol, alpha tocopherol and beta carotene in serum by isocratic high-performance liquid chromatography. J Chromatog 572: 103-116, 1991.
16. Arnaud J, Bellanger J, Bienvenu F, Chappuis P, Favier A: Méthode recommandée de dosage du zinc sérique par absorption atomique en flamme. Ann Biol Clin 44: 77-87, 1986.
17. Arnaud J, Prual A, Preziosi P, Favier A, Hercberg S: Selenium determination in human milk in Niger: influence of maternal status. J Trace Elem Electrolytes Health Dis 7: 199-204, 1993.
18. Bordet J.C, de Lorgeril M., Durbin S, Boissonnat P, Renaud S, Dureau G, Dechavanne M: Systemic but not renal production of prostacyclin is highly reduced in cyclosporin-treated heart transplant recipients. Am J Cardiol 72: 486-487, 1993.
19. Balazy M, Brass EP, Gerber JG, Nies AS: Facile method for preparation of 2,3-dinor-6-keto-PGF1alpha, the major metabolite of prostacyclin. Prostaglandins 36: 421-431, 1988.
20. Lellouche F, Fradin A, Fitzgerald G, Maclouf J: Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin. Prostaglandins 40: 297-310, 1990.
21. Nève J: New approaches to assess selenium status and requirement. Nutr Rev 58: 363-369, 2000.
22. Preziosi P, Galan P, Herbeth B, Valeix P, Roussel AM, Malvy D, Paul-Dauphin A, Arnaud J, Richard MJ, Briancon S, Favier A, Hercberg S: Effects of supplementation with a combination of antioxidant vitamins and trace elements at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects. J Am Coll Nutr 17: 244-249, 1998.
23. Frison L, Pocock SJ: Repeated measures in clinical trials: analysis using mean summary statistics and its implications for designs. Stat Med 11: 1685-1704, 1992.
24. van den Berg H, Heseker H, Lamand M, Sandström B, Thurnham D: Flair concerted action No 10 status papers. Internat J Vit Nutr Res 63: 247-316, 1993.
25. Malvy DJ, Favier A, Faure H, Preziosi P, Galan P, Arnaud J, Roussel AM, Briancon S, Hercberg S: Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.M.AX study. Cancer Detect Prev 25: 479-485, 2001
26. Hines LM, Rimm EB: Moderate alcohol consumption and coronary heart disease: a review. Postgrad Med J 77: 747-752, 2001.
27. Kratz A, Ferraro M, Sluss P, Lewandrowski LB: Laboratory reference values. N Engl Med J 351: 1548-1563, 2004.
28. Schindler TH, Lewandowski E, Olschewski M, Hasler K, Solzbach U, Just H: Wirkung von vitamin C auf die thrombozytenaggregation bei rauchern und nichtrauchern. Med Klin 97: 263-269, 2002.
29. Wilkinson IB, Megson IL, MacCallum H, Sogo N, Cockcroft JR, Webb DJ: Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovasc Pharmacol 34: 690-693, 1999.
30. Salonen JT, Salonen R, Seppanen K, Rinta-Kiikka S, Kuukka M, Korpela H, Alfthan G, Kantola M, Schalch W: Effects of antioxidant supplementation on platelet function: a randomized pairmatched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clin Nutr 53: 1222-1229, 1991.
31. Mensink RP, van Houwelingen AC, Kromhout D, Hornstra G: A vitamin E concentrate rich in tocotrienols had no effect on serum lipids, lipoproteins, or platelet function in men with mild elevated lipid concentrations. Am J Clin Nutr 69: 213-219, 1999.
32. Mutanen M, Viita L, Mykkanen HM: Selenium supplementation does not alter platelet activation in subjects with normal selenium status. Internat J Vit Nutr Res 59: 309-313, 1989.
33. Thomson CD: Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58: 391-402, 2004.
34. Patrignani P, Panara MR, Tacconelli S, Seta F, Bucciarelli T, Ciabattoni G, Alessandrini P, Mezzetti A, Santini G, Sciulli MG, Cipollone F, Davi G, Gallina P, Bon GB, Patrono C: Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 102: 539-545, 2000.
35. Gordon PR, Woodruff CW, Anderson HL, O'Dell BL: Effect of acute zinc deprivation on plasma zinc and platelet aggregation in adult males. Am J Clin Nutr 35: 113-119, 1982.
36. Ripa S, Ripa R: Zinco ed aterosclerosi. Minerva Med 85: 647-654, 1994.
37. Eisenmann CJ, Miller RK: The effect of selenium compounds (selenite, selenate, ebselen) on the production of thromboxane and prostacyclin by the human term placenta in vitro. Toxicol Appl Pharmacol 135: 18-24, 1995.
38. Chan AC: Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol 71: 725-731, 1993.
39. Cheng TY, Zhu Z, Masuda S, Morcos NC: Effects of multinutrient supplementation on antioxidant defense systems in healthy human beings. J Nutr Biochem 12: 388-395, 2001.
40. Douillet C, Bost M, Accominotti M, Borson-Chazot F, Ciavatti M: In vitro and in vivo effects of selenium with vitamin E on platelet functions in diabetic rats relationship to platelet sorbitol and fatty acid distribution. Biol Trace Elem Res 55: 263-277, 1996.
41. Wojcicki J, Rozewicka L, Barcew-Wiszniewska B, Samochowiec L, Juzwiak S, Kadlubowska D, Tustanowski S, Juzyszyn Z: Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 87: 9-16, 1991.